Navigation Links
Treating Knee Ligament Injuries
Date:3/2/2009

Identifying level of injury is key to treating MCLs nonsurgically, study finds

ROSEMONT, Ill., March 2 /PRNewswire-USNewswire/ -- Injuries to the knee's medial cruciate ligament (MCL) may be treated successfully without surgery, according to a literature review published in the March 2009 issue of The Journal of the American Academy of Orthopaedic Surgeons (JAAOS). The key, the review's authors found, is properly diagnosing and understanding the extent of the injury to determine the best course of treatment.

The MCL is the most frequently injured ligament in the knee. It attaches to the femur (thigh bone) and the tibia (shin bone) and runs across the inside of the knee. MCL injuries are usually caused by a direct blow to the knee, very common in contact sports such as football, rugby or soccer.

Injuries to the MCL may be isolated, or they may be part of a more complex injury involving the anterior cruciate ligament (ACL), posterior cruciate ligament (PCL) or meniscus (cartilage between the bones in the knee joint). Knowing whether other structures in the knee are involved is vital to treating these injuries.

"In most cases, MCL injuries can be treated non-operatively, with a combination of rehabilitation and bracing," says Ryan G. Miyamoto, M.D., sports medicine fellow at the Steadman-Hawkins Clinic in Vail, Colorado. "Surgery becomes an option when there are multiple injuries present in the knee. However, the additional injuries are not always identified."

Thorough physical examinations and appropriate imaging are of paramount importance in managing MCL injuries, say the study authors. In addition, they add that high-grade MCL injuries are often associated with other ligament injuries, so orthopaedic surgeons should pay particular attention to the other joint structures in those cases.

Non-surgical treatment of MCL injuries generally consists of:

  • Early rehabilitation with range of motion and strengthening exercises, along with use of a hinged knee brace.
  • Anti-inflammatory medications and low-intensity ultrasound are also being used with some success.
  • Other nonsurgical treatments, such as gene therapy, growth factors, and small intestine submucosa, which is a naturally derived biomaterial isolated from the small intestine of pigs.

All are currently in their early stages of use, but may hold some promise.

Surgical treatment of MCL injuries may include primary repair or reconstruction of the ligament(s), depending on the stability of the knee. Rehabilitation and bracing is required following surgery.

"We need to be very critical of the stability of the knee, which can be a factor in how well the knee heals and whether it is reinjured," Miyamoto says. "Injuries like these are best overseen by an orthopaedic surgeon."

saveyourknees.org

JAAOS

AAOS

Orthoinfo.org

Knee ligament injuries

Disclosure: The authors did not receive any outside funding or grants in support of their research for or preparation of this work. Neither they nor a member of their immediate families received payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, division, center, clinical practice, or other charitable or nonprofit organization with which the authors, or a member of their immediate families, are affiliated or associated.


'/>"/>
SOURCE American Academy of Orthopaedic Surgeons
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer
2. AcelRx Pharmaceuticals Reports Positive Results from a Clinical Trial of Sublingual Sufentanil/Triazolam NanoTab(TM) Combination (ARX-03) in Treating Procedural Pain and Anxiety
3. Alexzas AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial
4. First Clinical Experience With Soliris(R) in Treating Patients With Two Rare Complement-Mediated Diseases Presented at ASH Annual Meeting
5. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
6. Study Shows Potential Benefits of Xolair(R) in Treating Children Suffering from Moderate or Severe Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids
7. NanoBio Demonstrates New Topical Approach to Treating Nail Fungus That Circumvents Problems with Current Therapy
8. Pivotal Phase III Data Confirm the Efficacy and Safety of Arpidas Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections
9. Bioheart Announces 35 Leading U.S. Heart Failure Centers Engaged in Phase II/III Marvel Trial of Myogenic Cells for Treating Advanced Heart Failure
10. Experts Assert That Varian Technologies Deliver Speed and Clinical Accuracy in Treating Cancer Patients
11. Alexzas AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Divoti USA will engrave and process all non-coated stainless ... FDA requirements, which stipulates new criteria regarding medical device manufacture and ... ID jewelry such as Medical ID Bracelets, can rest assured that ... the new FDA requirements . ... Divoti offers this dark mark fiber laser engraving process with ...
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE ... team that developed an innovative way to use nonlinear ... the delivery of new drugs. ... Clinical Dermatology Conference will show how researchers from BioPharmX ... Harvard Medical School used a suite of imaging techniques ...
(Date:10/11/2017)... FRISCO, Texas , Oct. 11, 2017 /PRNewswire/ ... healthcare services, has amplified its effort during National ... patients about hereditary cancer risks. ... Journal of Clinical Oncology calculated that more than ... to have inherited mutations in BRCA1 or BRCA2 and ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance ... greater Dallas, Miami, and Raleigh regions, is organizing an extended charity drive to ... and deadly chromosome abnormality. , After struggling since birth with several health challenges, ...
(Date:10/13/2017)... ... 2017 , ... While it’s often important to take certain medications during the ... Texas, has identified a solution. , She developed a prototype for MOTION LIGHT-UP PILL ... it eliminates the need to turn on a light when taking medication during the ...
(Date:10/13/2017)... Las Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... of 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum ... CBD dose required and providing a CBD form that can be easily incorporated into ...
(Date:10/13/2017)... ... 13, 2017 , ... Apple Rehab Shelton Lakes , which specializes in ... the facility as part of a disaster drill on October 3rd. , Apple Rehab ... City Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
Breaking Medicine News(10 mins):